Literature DB >> 15596247

Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.

Yasuhide Mitsumoto1, Atsushi Mori, Satoshi Ohashi, Masami Nakai, Tetsuji Moriizumi.   

Abstract

The present study was undertaken to examine whether 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes damage of dopaminergic glomerular cells of the olfactory bulb (OB) in C57BL/6 mice. At 3 days after MPTP treatment, dopamine level in the striatum and the OB decreased to 13% and 84% of the control mice, respectively. While a small reduction of tyrosine hydroxylase protein level was observed in the OB of MPTP-treated mice, dopamine transporter (DAT) was undetectable at the protein level in this region. These results indicate that the DAT protein level could account for resistance of the OB to the Parkinsonism-inducing toxin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596247     DOI: 10.1016/j.neures.2004.09.012

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  6 in total

1.  Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.

Authors:  Yasuhide Mitsumoto; Atsushi Mori
Journal:  Neurosci Bull       Date:  2018-07-09       Impact factor: 5.203

2.  Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb.

Authors:  Renee Cockerham; Shaolin Liu; Roger Cachope; Emi Kiyokage; Joseph F Cheer; Michael T Shipley; Adam C Puche
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

3.  Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Argelia Esperanza Rojas-Mayorquin; Claudia P Figueiredo; Filipe C Matheus; Laure Ginestet; Caroline Chevarin; Elaine Del Bel; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

Review 4.  [Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].

Authors:  B Herting; S Bietenbeck; K Scholz; A Hähner; T Hummel; H Reichmann
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

5.  Drug-induced Parkinson's disease modulates protein kinase A and Olfactory Marker Protein in the mouse olfactory bulb.

Authors:  Carla Mucignat; Antonio Caretta
Journal:  Behav Brain Funct       Date:  2017-01-26       Impact factor: 3.759

6.  Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys.

Authors:  Christian Pifl; Harald Reither; Natalia Lopez-Gonzalez Del Rey; Carmen Cavada; Jose A Obeso; Javier Blesa
Journal:  Front Neuroanat       Date:  2017-05-29       Impact factor: 3.856

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.